Monitoring requirements Qsymia requires more routine monitoring than GLP-1 medications: Monthly pregnancy tests for women of childbearing age Regular heart rate monitoring Periodic blood work for bicarbonate levels (metabolic acidosis screening) Kidney function tests Mood and cognition assessment GLP-1 medications generally require less intensive monitoring, though periodic blood work to check pancreatic enzymes and kidney function is still recommended
*Enhanced Athletic Performance*: L-Carnitine may improve exercise performance and reduce muscle fatigue
It helps lower blood sugar levels by stimulating insulin production and reducing appetite, making it an effective option for managing type 2 diabetes and supporting weight loss
See Bacteriostatic Water 10 ml and GH-axis research companions such as CJC-1295 (No DAC) 5 mg and GHRP-6 5 mg
Side effects include, but are not limited to, nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder)